Abstract
Lactic acid bacteria (LAB) are gaining importance due to their “generally recognized as safe” status, long-term use in food and beneficial, probiotic properties. They can acquire new, desirable traits by the incorporation of genes that allow the expression of heterologous proteins, and several patents and patent applications describe the use of recombinant LAB. We first focus on the available expression systems, their improvement towards “food-grade” status, and modes of regulating the expression. LAB have been used as vehicles for the delivery of proteins to the mucosal surfaces. Delivered proteins may interact with the immune system and have been shown to be effective, either as vaccines or as toleranceinducing, anti-allergy agents in mice. Proteins with biological functions that could be used in therapy have also been delivered. Delivery of interleukin 10 (IL-10) in Crohns disease, which was tested in a human phase I clinical trial and has proceeded to phase IIa, is the first example of use of recombinant LAB in humans. Another field of recombinant LAB application is metabolic engineering. Existing metabolic pathways have been modified to improve the properties of LAB as food fermentation starters, and heterologous metabolic enzymes have been introduced to LAB for the production of industrially relevant chemicals.
Keywords: Lactic acid bacteria, Lactococcus, Lactobacillus, recombinant protein, vaccine, allergen, antigen, expression, delivery, metabolic engineering
Recent Patents on Biotechnology
Title: Novel Applications of Recombinant Lactic Acid Bacteria in Therapy and in Metabolic Engineering
Volume: 3 Issue: 2
Author(s): Ales Berlec and Borut Strukelj
Affiliation:
Keywords: Lactic acid bacteria, Lactococcus, Lactobacillus, recombinant protein, vaccine, allergen, antigen, expression, delivery, metabolic engineering
Abstract: Lactic acid bacteria (LAB) are gaining importance due to their “generally recognized as safe” status, long-term use in food and beneficial, probiotic properties. They can acquire new, desirable traits by the incorporation of genes that allow the expression of heterologous proteins, and several patents and patent applications describe the use of recombinant LAB. We first focus on the available expression systems, their improvement towards “food-grade” status, and modes of regulating the expression. LAB have been used as vehicles for the delivery of proteins to the mucosal surfaces. Delivered proteins may interact with the immune system and have been shown to be effective, either as vaccines or as toleranceinducing, anti-allergy agents in mice. Proteins with biological functions that could be used in therapy have also been delivered. Delivery of interleukin 10 (IL-10) in Crohns disease, which was tested in a human phase I clinical trial and has proceeded to phase IIa, is the first example of use of recombinant LAB in humans. Another field of recombinant LAB application is metabolic engineering. Existing metabolic pathways have been modified to improve the properties of LAB as food fermentation starters, and heterologous metabolic enzymes have been introduced to LAB for the production of industrially relevant chemicals.
Export Options
About this article
Cite this article as:
Berlec Ales and Strukelj Borut, Novel Applications of Recombinant Lactic Acid Bacteria in Therapy and in Metabolic Engineering, Recent Patents on Biotechnology 2009; 3 (2) . https://dx.doi.org/10.2174/187220809788700175
DOI https://dx.doi.org/10.2174/187220809788700175 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advancements in Plant Genetics and Genomics
This thematic issue will highlight cutting-edge innovations and recent patents across the breadth of plant genetics and genomics. Key topics will include advanced breeding techniques, omics-based approaches, gene editing, trait discovery, and translational applications for crop improvement. Renowned researchers from leading institutions worldwide will provide state-of-the-art insights and future perspectives ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis
Current Genomics The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis
Current Signal Transduction Therapy Colorectal Cancer – Increased Multidimensional Understanding of the Molecular Genesis
Current Cancer Therapy Reviews Insight into p95HER2 in Breast Cancer: Molecular Mechanisms and Targeted Therapies
Recent Patents on DNA & Gene Sequences Proinflammatory Activities of Leptin in Non-Autoimmune Conditions
Inflammation & Allergy - Drug Targets (Discontinued) Potential Applications of Bacterial Cellulose in Environmental and Pharmaceutical Sectors
Current Pharmaceutical Design Electrochemical Study of DNA Damaged by Oxidation Stress
Combinatorial Chemistry & High Throughput Screening Targeted Strategies in the Treatment of Primary Gastric Lymphomas: From Rituximab to Recent Insights into Potential New Drugs
Current Medicinal Chemistry Antisense Strategies
Current Molecular Medicine Hardware and Software Approaches to Multi-Modality Imaging
Current Medical Imaging Chemotherapy in Addition to Preoperative Radiotherapy in Locally Advanced Rectal Cancer – A Systematic Overview
Reviews on Recent Clinical Trials Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation
Current Pharmaceutical Design Anti-Inflammatory Agents from Plants: Progress and Potential
Current Medicinal Chemistry Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy Emerging Trends in Endometriosis Treatment - Review
Current Women`s Health Reviews Dietary Quercetin Alleviated DSS-induced Colitis in Mice Through Several Possible Pathways by Transcriptome Analysis
Current Pharmaceutical Biotechnology Post-Exercise Ketosis, Salivary Uric Acid and Interleukin-6 after a Simulated Wheelchair Basketball Match
Endocrine, Metabolic & Immune Disorders - Drug Targets Lactococcus lactis as a Cell Factory for Delivery of Therapeutic Proteins
Current Gene Therapy Role of Free Fatty Acid Receptor 2 (FFAR2) in the Regulation of Metabolic Homeostasis
Current Drug Targets New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry